Chronic News and Research

RSS

New report highlights patient-centered medical home's impact on quality, costs

Today at a briefing on Capitol Hill, the Patient-Centered Primary Care Collaborative released a new publication highlighting the significant impact the patient-centered medical home (PCMH) has on improving quality and reducing costs of primary care delivery.

30 Jan 2015

OSTAR introduces Cellular TeleHealth Blood Pressure Monitoring System in North America

OSTAR Healthcare Technology, a Washington State Based TeleHealth Solutions company, announced the North American launch of yet another first in their Cellular TeleHealth Blood Pressure Monitoring System.

30 Jan 2015

Centura Health, DaVita HealthCare Partners jointly unveil FullWell

Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas.

30 Jan 2015

K. Hovnanian Children's Hospital introduces Meridian Dentistry for Children

K. Hovnanian Children's Hospital at Jersey Shore University Medical Center introduces Meridian Dentistry for Children, a specialized, full-service, dental practice for infants, children and adolescents in a child-friendly, caring environment.

30 Jan 2015

Texting better than apps to treat people with mental illness

Texting may be a more suitable treatment aid for those with mental illness than mobile applications.

30 Jan 2015

Negative communication between doctor and patient could make symptoms worse

Doctors who unintentionally communicate to patients that they don't believe or understand them could actually make symptoms worse, a new study suggests.

30 Jan 2015

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).

30 Jan 2015

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

The farnesoid-X receptor (FXR), also known as the chief regulator of bile acid metabolism, is thought to play a role in some hepatobiliary and gastrointestinal disorders.

30 Jan 2015

Cardiologist promotes the importance of controlling high blood pressure

During Heart Month, the Cardiovascular Institute of New Jersey at Rutgers Robert Wood Johnson Medical School is promoting the importance of controlling high blood pressure, also called hypertension, in order to reduce the risk of coronary heart disease and other related chronic disorders in adults.

30 Jan 2015

Magnus Life Science commemorates unique partnership with UCL to advance bio-medical research

Magnus Life Science is today celebrating its unique collaboration with University College London (UCL), one of the world's leading universities, to advance bio-medical research and bring real innovation to areas of high unmet medical need.

29 Jan 2015

electroCore’s non-invasive vagus nerve stimulation therapy safe, effective across a variety of conditions

Non-invasive vagus nerve stimulation (nVNS) ‘improves the safety and tolerability of VNS making it more accessible and facilitating further investigations across a wide range of uses when compared with surgically implanted VNS’ according to a review in the European Journal of Neurology.

29 Jan 2015

DePuy Synthes Spine receives 510(k) clearance to market SYNAPSE OCT System with posterior cervical screws

DePuy Synthes Spine today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SYNAPSETM Occipital-Cervical-Thoracic (OCT) System with posterior cervical screws, the first time cervical screws have been indicated for use with a screw-rod posterior fixation system.

29 Jan 2015

Quest Diagnostics, CDC partner to identify trends in diagnosis and treatment for viral hepatitis

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced that it will collaborate with the Centers for Disease Control and Prevention to identify trends in screening, diagnosis and treatment for four strains of viral hepatitis in the United States, based on insights revealed by analysis of Quest’s national testing database.

From Quest Diagnostics 29 Jan 2015

OCC partners commend EU decision that supports disability protections for obesity

In a joint position statement, Obesity Care Continuum (OCC) partners agree with the premise behind a recent European Court of Justice ruling supporting disability protections for obesity under certain circumstances and call for these protections to be enacted in the United States.

29 Jan 2015

Young Researcher's Meeting on Primary Ciliary Dyskinesia to be held in Bern, Switzerland

Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous disorder that affects approximately 1 in 20,000 individuals.

29 Jan 2015

Researchers discover novel compound that helps curtail progression of temporal lobe epilepsy

Researchers at the LSU Health New Orleans Neuroscience Center of Excellence have found that a novel compound they discovered helps curtail the onset and progression of temporal lobe epilepsy.

28 Jan 2015

Tenofovir stems treatment-induced kidney toxicity in HBV-related chronic hepatitis

Switching to tenofovir may stave further kidney and bone impairment in patients with hepatitis B virus-related chronic hepatitis taking adefovir-based therapy, retrospective study findings suggest.

28 Jan 2015

Long-term TDF therapy offers sustained HBV suppression without resistance

Patients with chronic hepatitis B virus infection can achieve sustained viral suppression with long-term tenofovir disoproxil fumarate treatment without developing resistance, shows a 7-year study.

28 Jan 2015

Quest Diagnostics, CDC collaborate to reduce deaths from hepatitis

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it will collaborate with the Centers for Disease Control and Prevention to identify trends in screening, diagnosis and treatment for four strains of viral hepatitis in the United States, based on insights revealed by analysis of Quest's national testing database.

From Quest Diagnostics 28 Jan 2015

HCI researchers find cell mechanism that may trigger pancreatic cancer

Researchers at Huntsman Cancer Institute at the University of Utah have found that defects in how cells are squeezed out of overcrowded tissue to die, a process called extrusion, may be a mechanism by which pancreatic cancer begins. From these findings, they may have identified an effective way to reverse the defective extrusion's effects without destroying normal tissues nearby.

28 Jan 2015

Chronic News and Research

New report highlights patient-centered medical home's impact on quality, costs

OSTAR introduces Cellular TeleHealth Blood Pressure Monitoring System in North America

Centura Health, DaVita HealthCare Partners jointly unveil FullWell

K. Hovnanian Children's Hospital introduces Meridian Dentistry for Children

Texting better than apps to treat people with mental illness

Negative communication between doctor and patient could make symptoms worse

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

Cardiologist promotes the importance of controlling high blood pressure

Magnus Life Science commemorates unique partnership with UCL to advance bio-medical research

electroCore’s non-invasive vagus nerve stimulation therapy safe, effective across a variety of conditions

DePuy Synthes Spine receives 510(k) clearance to market SYNAPSE OCT System with posterior cervical screws

Quest Diagnostics, CDC partner to identify trends in diagnosis and treatment for viral hepatitis

OCC partners commend EU decision that supports disability protections for obesity

Young Researcher's Meeting on Primary Ciliary Dyskinesia to be held in Bern, Switzerland

Researchers discover novel compound that helps curtail progression of temporal lobe epilepsy

Tenofovir stems treatment-induced kidney toxicity in HBV-related chronic hepatitis

Long-term TDF therapy offers sustained HBV suppression without resistance

Quest Diagnostics, CDC collaborate to reduce deaths from hepatitis

HCI researchers find cell mechanism that may trigger pancreatic cancer

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News